A product that is built and approved still has to be sold. Bayeux closes the loop with a hospital and surgeon network built over years — connecting the finished product to the clinicians who adopt it.
Reaching the market in the GCC and Egypt means navigating procurement systems unlike any other region, engaging clinical networks built on personal relationships, and developing distributor partnerships that reflect how product actually moves. Bayeux closes the loop using a hospital and surgeon network built over years of operating in the clinical environment — not assembled for an engagement. Commercial launch is the final stage of the same project, executed by the same team.
Procurement, clinical and regulatory access — solved together — to connect a finished product to the institutions that adopt it.
Plans built for the specific product, regulatory status and commercial profile of each market — pricing, procurement channel identification, tender preparation, hospital access and clinical engagement. A strategy that treats the GCC as one market fails in practice.
Partners selected on regulatory capability, cold chain infrastructure, hospital relationships and willingness to drive adoption — not just move units. Agreements structured to hold distributors accountable and protect the client's registrations.
A surgeon and hospital network across Saudi Arabia, the UAE and Egypt built at the individual relationship level — Bayeux's most distinctive commercial asset, and what most directly determines whether a product reaches the clinicians who adopt it.
The full national tender cycle managed — product listing, pricing strategy, documentation, submission and award follow-through — so the client is positioned to win national procurement volume, not just participate.
Built from market reality — pricing architecture by market and channel, competitive positioning, clinical evidence strategy, launch sequencing and a sales model designed for the specific product and team.
A product that's approved still has to be chosen. We make sure it is.Market Entry & Commercialization
Doctor-led, end-to-end development of medical device and pharmaceutical ventures across the GCC and Egypt. We don't just advise — we build.